Learn More
Invivogen Enpatoran, Dual TLR7/TLR8 Inhibitor, 95% Purity, 20 mg/ml Solubility

Supplier: Invivogen INHM5049
Enpatoran is a selective dual inhibitor of TLR7 and TLR8, blocking key pathways to mitigate autoimmune responses. With high efficacy in various in vitro assays and promising results in mouse models for systemic lupus erythematosus and severe COVID-19, it stands out due to its unique mechanism of stabilizing TLR8 dimers in an inactive state. Its 100% oral bioavailability in mice further ensures effective treatment delivery.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.